Human epidermal growth factor receptor 2 (HER2) is a family of transmembrane receptor tyrosine kinases encoded by the ERBB2 gene, which has been an important area of research and treatment target in breast cancer [1]. This evidence concerns the gene ERBB2 and breast carcinoma.